Description
Success Stories From Small Molecule Drug Product
Success Stories From Small Molecule Drug Product Significant progress in CM implementation has been made over the last ten years. From fundamental studies within academia to global drug product CM approvals, CM represents a paradigm shift within the industry that will continue to grow with time. In this session, success stories from some of the early adopters and implementers will be shared which include regulatory, technical, and business-related achievements in the hope that it will encourage others to join the CM movement!
- Leveraging Continuous Manufacturing to Enable Real Time Release Testing
Joseph Medendorp, Senior Director, Technical Operations
Vertex
- Particle Design and Engineering to Enable Continuous Direct Compression Manufacturing Processes
Jeremy Merritt, PhD, Principal Research Scientist, Particle Design Lab – Small Molecule Design & Development
Eli Lilly and Company Janssen
- CM-strategy: A Story of Multiple Platforms From R&D to Commercial
Jeroen Geens, Engineering Technical Director – New Platforms
Janssen
Moderator(s):
- Wyatt
Roth,
PhD,
Senior Research Scientist,
Eli Lilly and Company
Speaker(s):
- Joseph
Medendorp,
PhD,
Senior Director, Technical Operations,
Vertex
- Jeremy
Merritt,
PhD,
Principal Research Scientist,
Eli Lilly and Company
- Jeroen
Geens,
PhD,
Engineering Technical Director, New Platforms,
Janssen Research & Development
